Novos

Develops nutraceuticals to slow down aging

placeNew York City, New York, United States calendar_todayFounded 2019 groups4 employees language novoslabs.com

Registered entities

Reputation

Customer rating 4.1 / 5 across 154 reviews.

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
United States42.3%
Argentina16.9%
United Kingdom12.3%
India10.3%
Brazil3.7%

Social engagement

Social engagement: 11.7K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Resolute Ventures.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Share of voice

Share of voice in United States: 27.2% of web traffic across its competitive set; worldwide: 11.5%.

Recent activity

2 Feb 2026
Partnership
Truemed
25 Sep 2025
Recognition
Coming soon